Demographic drivers, rising healthcare spending, research-focused clusters and strong government support are providing growth opportunities for Asia Pacific life sciences and R&D platform Vita Partners, attendees learned at Mingtiandi’s 2025 Singapore Forum on Tuesday.
Vita has more than S$2 billion… Read More>>